Trials / Completed
CompletedNCT01012687
Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalency Study of Perindopril Erbumine Tablets 8 mg Under Fasting Conditions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Roxane Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to prove the bioequivalence of Perindopril Erbumine 8 mg tablets under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | perindopril erbumine | 8 mg tablet |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2007-05-01
- Completion
- 2007-05-01
- First posted
- 2009-11-13
- Last updated
- 2018-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01012687. Inclusion in this directory is not an endorsement.